Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: J Subst Abuse Treat. 2013 Mar 19;45(2):190–195. doi: 10.1016/j.jsat.2013.02.001

Table 1.

Baseline Characteristics of Patients in Italian Opioid Treatment Programs Participating in Project Outcome in 2010. (N = 8,145)

Variable Total
Sample
Buprenorphine
(n = 2,257)
Methadone
(n = 5,888)
p
Age, mean (SD) 37.0 (8.9) 35.8 (8.8) 37.4 (8.9) <.001
Male, n (%) 6,857 (84.2%) 1,969 (87.2%) 4,888 (83.0%) <.001
Nationality, n (%)
  Italian 7,915 (97.2%) 2,216 (98.2%) 5,699 (96.8%) .001
  Other 228 (2.8%) 41 (1.8%) 187 (3.2%) .001
Married an (%) 1,275 (17.8%) 378 (18.8%) 897 (17.4%) .143
Employed 1bn (%) 4,912 (63.7%) 1,503 (70.1%) 3,409 (61.2%) <.001
Educational level2,cn (%) 1,738 (23.4%) 558 (26.8%) 1,180 (22.0%) <.001
Age of first opiate use, mean (SD) 21.6 (6.2) 22.0 (6.1) 21.4 (6.2) .001
Injected drugs 3,dn (%) 2,903 (74.3%) 625 (64.1%) 2,278 (77.6%) <.001
Secondary Cocaine or Crack Use, n (%) 2,382 (29.2%) 595 (26.4%) 1,787 (30.3%) <.001
1

Employed either permanently or temporarily

2

Completed at least upper middle school

3

Including heroin, methadone or other opioids

a

Missing data as follows: 11.1%; 12.2%; and, 11.9% for buprenorphine, methadone and total samples.

b

Missing data as follows: 5.1%; 5.3%; and,, 5.3% for buprenorphine, methadone, and total samples.

c

Missing data as follows: 7.9%; 9.0%; and, 8.7% for buprenorphine, methadone, and total samples.

d

Missing data as follows: 56.8%; 50.2%; and, 52.0% for buprenorphine, methadone, and total samples.